Vivani Medical VANI 深 滬
等待開盤 09-25 09:30:00 美东时间
1.23
0.000
0.00%
華盛通- 最 高1.24
- 今 開1.23
- 成交量 7.96万股
- 最 低 1.22
- 昨 收 1.23
- 總市值 1.11亿
- 52周最高 1.92
- 市盈率 靜 --
- 換手率 0.09%
- 52周最低 0.9228
- 委 比 64.37%
- 總股本 9020.34万
- 歷史最高 576.48
- 量 比 0.25
- 振 幅 1.63%
- 歷史最低 0.7536
- 每 手 1
- 風險率 0.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Vivani Medical Announces Merger Deal Involving Cortigent
The latest announcement is out from Vivani Medical ( ($VANI) ). Vivani Medical,...
09-17 04:54
Vivani Medical Q2 EPS $(0.07) Beats $(0.08) Estimate
Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 41.67 percent increase over losses of $(0.12) per share from the same period last year.
08-14 04:21
ClearOne To Acquire Vivani Medical Subsidiary Cortigent For 12.5M Shares Of CLRO Worth ~$40.4M; ClearOne To File S-1 Seeking To Raise $10M-$15M
Vivani Medical, Inc. (NASDAQ:VANI) ("Vivani"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that it has entered into a definitive agreement and plan of merger (the "Agreement") among its wholly owned subsidiary Cortigent, Inc. ("Co...
07-02 20:03
美股大行评级 | 美银上调美光科技目标价从950美元升至1500美元，上调迈威尔科技目标价从240美元升至365美元
今日重点评级关注：摩根士丹利：维持杜邦"标配"评级，目标价从52美元升至156美元；蒙特利尔银行：维持Taysha Gene Therapies"跑赢大市"评级，目标价从10美元升至14美元
06-24 14:08
Lake Street Initiates Coverage On Vivani Medical with Buy Rating, Announces Price Target of $4
Lake Street analyst Thomas Flaten initiates coverage on Vivani Medical (NASDAQ:VANI) with a Buy rating and announces Price Target of $4.
06-23 22:24
Vivani Medical Q4 EPS $(0.09) Beats $(0.10) Estimate.
Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 percent. This is a 18.18 percent increase over losses of $(0.11) per share from the
03-27 04:49
